Blaithin A McMahon1, Jay L Koyner2, Tessa Novick1, Steve Menez1, Robert A Moran3, Bonnie E Lonze4, Niraj Desai4, Sami Alasfar1,4, Marvin Borja4, William T Merritt5, Promise Ariyo5, Lakhmir S Chawla6, Edward Kraus1,4. 1. a Division of Nephrology , Johns Hopkins University School of Medicine , Baltimore , MD , USA. 2. b Section of Nephrology, Department of Medicine , University of Chicago , Chicago , IL , USA. 3. c Division of Gastroenterology, Johns Hopkins University School of Medicine , Baltimore , MD , USA. 4. d Comprehensive Renal Transplantation Unit , Johns Hopkins University School of Medicine , Baltimore , MD , USA. 5. e Johns Hopkins Anesthesiology and Critical Care Medicine , Baltimore , MD , USA. 6. f Department of Medicine, Division of Intensive Care Medicine and Division of Nephrology , Veterans Affairs Medical Center , Washington DC , USA.
Abstract
OBJECTIVES AND METHODS: The Furosemide Stress Test (FST) is a novel dynamic assessment of tubular function that has been shown in preliminary studies to predict patients who will progress to advanced stage acute kidney injury, including those who receive renal replacement therapy (RRT). The aim of this study is to investigate if the urinary response to a single intraoperative dose of intravenous furosemide predicts delayed graft function (DGF) in patients undergoing deceased donor kidney transplant. RESULTS: On an adjusted multiple logistic regression, a single 100 mg dose of intraoperative furosemide after the anastomosis of the renal vessels (FST) predicted the need for RRT at 2 and 6 h post kidney transplantation (KT). Recipient urinary output was measured at 2 and 6 h post furosemide administration. In receiver-operating characteristic (ROC) analysis, the FST predicted DGF with an area-under-the curve of 0.85 at an optimal urinary output cut-off of <600 mls at 6 h with a sensitivity of and a specificity of 83% and 74%, respectively. CONCLUSIONS: The FST is a predictor of DGF post kidney transplant and has the potential to identify patients requiring RRT early after KT.
OBJECTIVES AND METHODS: The Furosemide Stress Test (FST) is a novel dynamic assessment of tubular function that has been shown in preliminary studies to predict patients who will progress to advanced stage acute kidney injury, including those who receive renal replacement therapy (RRT). The aim of this study is to investigate if the urinary response to a single intraoperative dose of intravenous furosemide predicts delayed graft function (DGF) in patients undergoing deceased donor kidney transplant. RESULTS: On an adjusted multiple logistic regression, a single 100 mg dose of intraoperative furosemide after the anastomosis of the renal vessels (FST) predicted the need for RRT at 2 and 6 h post kidney transplantation (KT). Recipient urinary output was measured at 2 and 6 h post furosemide administration. In receiver-operating characteristic (ROC) analysis, the FST predicted DGF with an area-under-the curve of 0.85 at an optimal urinary output cut-off of <600 mls at 6 h with a sensitivity of and a specificity of 83% and 74%, respectively. CONCLUSIONS: The FST is a predictor of DGF post kidney transplant and has the potential to identify patients requiring RRT early after KT.
Authors: O G Rewa; S M Bagshaw; X Wang; R Wald; O Smith; J Shapiro; B McMahon; K D Liu; S A Trevino; L S Chawla; J L Koyner Journal: J Crit Care Date: 2019-04-09 Impact factor: 3.425
Authors: Ekamol Tantisattamo; Miklos Z Molnar; Bing T Ho; Uttam G Reddy; Donald C Dafoe; Hirohito Ichii; Antoney J Ferrey; Ramy M Hanna; Kamyar Kalantar-Zadeh; Alpesh Amin Journal: Front Med (Lausanne) Date: 2020-06-16
Authors: Armando Coca; Carmen Aller; Jimmy Reinaldo Sánchez; Ana Lucía Valencia; Elena Bustamante-Munguira; Juan Bustamante-Munguira Journal: Int J Mol Sci Date: 2020-04-27 Impact factor: 5.923